Cover Image

Antimicrobial exposure and risk of depression

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Y. W. Francis Lam
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	The Brown University Psychopharmacology Update
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmacological treatments for psychotic depression
by: Y. W. Francis Lam
Published: (2024)

Impact of CYP2D6 genotype on fluoxetine exposure
by: Y. W. Francis Lam
Published: (2025)

Clozapine‐associated pneumonia
by: Y. W. Francis Lam
Published: (2025)

Psychotropic‐induced lipid disturbances
by: Y. W. Francis Lam
Published: (2025)

Psychotropic‐induced weight gain and telomere length
by: Y. W. Francis Lam
Published: (2025)

Antidepressant use and stroke‐related outcomes
by: Y. W. Francis Lam
Published: (2025)

Real‐world usage of paliperidone palmitate injection
by: Y. W. Francis Lam
Published: (2025)

Differences among methylphenidate products
by: Y. W. Francis Lam
Published: (2025)

Clozapine‐induced third‐degree atrioventricular block and respiratory failure
by: Y. W. Francis Lam
Published: (2026)

Neuropsychiatric effects of glucocorticoids
by: Y. W. Francis Lam
Published: (2024)

Impact of maternal acetaminophen use on child neurodevelopment
by: Y. W. Francis Lam
Published: (2026)

Clozapine concentration and adverse reactions: Impact of smoking
by: Y. W. Francis Lam
Published: (2026)

Antidepressants and changes in adiposity
by: Y. W. Francis Lam
Published: (2024)

Lamotrigine and quetiapine interaction
by: Y. W. Francis Lam
Published: (2024)

Risk of falls in bupropion‐treated older adults
by: Y. W. Francis Lam
Published: (2026)

Appropriate use of anticholinergics
by: Y. W. Francis Lam
Published: (2024)

Antipsychotic‐associated breast cancer
by: Y. W. Francis Lam
Published: (2024)

Quetiapine co‐administration with fluvoxamine and duloxetine
by: Y. W. Francis Lam
Published: (2024)

Oxcarbazepine and clozapine interaction
by: Y. W. Francis Lam
Published: (2024)

Impact of antidepressants' serotonin transporter affinity on bleeding events
by: Y. W. Francis Lam
Published: (2026)

Study finds association between levonorgestrel exposure, depression
Published: (2024)

Study finds no link between prenatal antidepressant exposure and childhood depression
Published: (2025)

Postpartum hormonal contraceptives increase risk of depression
Published: (2025)

Antidepressants for bipolar depression do not increase risk of mania
Published: (2024)

First‐line antidepressants decrease fall risk in elderly with depression
Published: (2024)

Low dose of esketamine after childbirth helps mothers at risk of depression
Published: (2024)

Paternal exposure to valproate linked to higher risk of neurodevelopmental disorders in offspring
Published: (2026)

Prenatal exposure to benzodiazepines linked to long‐term risk of neurodevelopmental disorders
Published: (2026)

Fremanezumab effective for comorbid migraine and depression
Published: (2025)

Esketamine monotherapy efficacious in treatment‐resistant depression
Published: (2025)

Pharmacogenomic testing influenced prescribing in patients with depression
Published: (2025)

Lumateperone effective as adjunctive therapy in patients with depression
Published: (2025)

Postpartum use of dexmedetomidine reduces incidence of depression
Published: (2024)

Adjunctive aticaprant reduces symptoms in patients with depression
Published: (2024)

Control group improvement lower in psilocybin trials for depression
Published: (2025)

Review confirms antidepressant efficacy in post‐MI depression
Published: (2025)

Mixed results for esmethadone in Phase 3 depression trial
Published: (2024)

Adjunctive dextromethorphan/quinidine promising in pilot study for depression
Published: (2024)

Oral formulation of ketamine effective for treatment‐resistant depression
Published: (2024)

Gepirone ER not linked to sexual dysfunction in patients with depression
Published: (2024)